CAS 1232221-74-7

4-{5-[(E)-2-[(3-methylphenyl)methylidene]hydrazin-1-yl]-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl}morpholine

CAS : 1232221-74-7

Formule : C₂₃H₂₃N₇O

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 413.4750

Ref: IN-DA009CGV

APY0201

CAS : 1232221-74-7

APY0201

Degré de pureté : ≥98%

Masse moléculaire : 413.48g/mol

Ref: 54-BUP02150

APY0201

CAS : 1232221-74-7

APY0201 is a biological product that is used to treat autoimmune diseases. It is a cell-based therapy that has been shown to have cytotoxic effects on target tissues, including cancerous tissues and virus-infected cells. The product is administered orally and its effective dose is dependent on the localisation of the cells in the body and their sensitivity to APY0201. APY0201 has been shown to be effective against eye disorders such as uveitis, optic neuritis, and glaucoma. This drug can be applied at nanomolar concentrations for localized delivery of therapeutics for these conditions.

Formule : C₂₃H₂₃N₇O

Degré de pureté : Min. 95%

Masse moléculaire : 413.48 g/mol

Ref: 3D-BA177440

APY0201

CAS : 1232221-74-7

APY0201: potent, specific ATP-competitive PIKfyve inhibitor; IC50=5.2 nM; blocks PtdIns3P to PtdIns(3,5)P2 conversion.

Formule : C₂₃H₂₃N₇O

Degré de pureté : 98% - 99.74%

Couleur et forme : Solid

Masse moléculaire : 413.48

Ref: TM-T2061